{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T22:54:06Z","timestamp":1793141646744,"version":"4.5.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,28]],"date-time":"2022-05-28T00:00:00Z","timestamp":1653696000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,28]],"date-time":"2022-05-28T00:00:00Z","timestamp":1653696000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81860281"],"award-info":[{"award-number":["81860281"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81860281"],"award-info":[{"award-number":["81860281"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81860281"],"award-info":[{"award-number":["81860281"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81860281"],"award-info":[{"award-number":["81860281"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Objective<\/jats:title><jats:p>To explore the appropriate dosage of levothyroxine treatment for congenital hypothyroidism patients with different thyroid stimulating hormone (TSH) levels.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A total of 116 patients, who were regularly followed-up in our endocrine clinic from January 2010 to December 2020, were divided into four groups based on their thyroid function (group A: TSH\u2009\u2265\u2009100 mIU\/L, group B: TSH\u2009\u2265\u200920, and\u2009&lt;\u2009100, group C: TSH\u2009&gt;\u20094.6 mIU\/L and\u2009&lt;\u200920 mIU\/L with free thyroxine (FT4)\u2009&lt;\u20096.6\u2009pmol\/L, and group D: TSH\u2009&gt;\u20094.6 mIU\/L and\u2009&lt;\u200920 mIU\/L with FT4\u2009&gt;\u20096.6\u2009pmol\/L). The initial dosage of levothyroxine was individualized for each patient based on their TSH level and then adjusted according to their thyroid function at every follow-up time point. The levothyroxine dosage at each time point was compared between the groups, and thyroid function and physical and neurological development after treatment were also compared.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>After individualized dosage adjustment, all patients achieved normal thyroid function. Although there were statistical differences in neurological development between the four groups (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05), development was within the normal range for all groups.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>An individualized levothyroxine dosage can provide the same therapeutic effect compared to the recommended dosage. This strategy may also reduce the risk of a drug overdose.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12902-022-01061-z","type":"journal-article","created":{"date-parts":[[2022,5,28]],"date-time":"2022-05-28T13:05:43Z","timestamp":1653743143000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Levothyroxine treatment for congenital hypothyroidism based on thyroid function: a 10-year clinical retrospective study"],"prefix":"10.1186","volume":"22","author":[{"given":"Shan","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinghui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,28]]},"reference":[{"issue":"3","key":"1061_CR1","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1089\/thy.2020.0333","volume":"31","author":"P van Trotsenburg","year":"2021","unstructured":"van Trotsenburg P, Stoupa A, Leger J, Rohrer T, Peters C, Fugazzola L, et al. Congenital hypothyroidism: a 2020-2021 consensus guidelines update-an ENDO-European reference network initiative endorsed by the European Society for Pediatric Endocrinology and the European Society for Endocrinology. Thyroid. 2021;31(3):387\u2013419.","journal-title":"Thyroid"},{"issue":"2","key":"1061_CR2","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1210\/jc.2013-1891","volume":"99","author":"J Leger","year":"2014","unstructured":"Leger J, Olivieri A, Donaldson M, Torresani T, Krude H, van Vliet G, et al. European Society for Paediatric Endocrinology consensus guidelines on screening, diagnosis, and management of congenital hypothyroidism. J Clin Endocrinol Metab. 2014;99(2):363\u201384.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"1061_CR3","first-page":"421","volume":"49","author":"Subspecialty Group of Endocrinologic H, metabolic diseases TSoPCMA, Group for Newborn Screening SoCHCPMA","year":"2011","unstructured":"Subspecialty Group of Endocrinologic H, metabolic diseases TSoPCMA, Group for Newborn Screening SoCHCPMA. Consensus statement on the diagnosis and management of congenital hypothyroidism. Zhonghua Er Ke Za Zhi. 2011;49(6):421\u20134.","journal-title":"Zhonghua Er Ke Za Zhi"},{"issue":"10","key":"1061_CR4","doi-asserted-by":"publisher","first-page":"e4231","DOI":"10.1210\/clinem\/dgab209","volume":"106","author":"JC Naafs","year":"2021","unstructured":"Naafs JC, Marchal JP, Verkerk PH, Fliers E, van Trotsenburg ASP, Zwaveling-Soonawala N. Health-related quality of life in patients with early-detected central congenital hypothyroidism. J Clin Endocrinol Metab. 2021;106(10):e4231\u201341.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"1061_CR5","doi-asserted-by":"publisher","first-page":"2290","DOI":"10.1542\/peds.2006-0915","volume":"117","author":"SR Rose","year":"2006","unstructured":"American Academy of P, Rose SR, Section on E, Committee on Genetics ATA, Brown RS, Public Health Committee LWPES, et al. Update of newborn screening and therapy for congenital hypothyroidism. Pediatrics. 2006;117(6):2290\u2013303.","journal-title":"Pediatrics"},{"issue":"1","key":"1061_CR6","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s12020-019-02024-6","volume":"66","author":"AJ Bauer","year":"2019","unstructured":"Bauer AJ, Wassner AJ. Thyroid hormone therapy in congenital hypothyroidism and pediatric hypothyroidism. Endocrine. 2019;66(1):51\u201362.","journal-title":"Endocrine"},{"issue":"1","key":"1061_CR7","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1097\/MED.0000000000000520","volume":"27","author":"CE Cherella","year":"2020","unstructured":"Cherella CE, Wassner AJ. Update on congenital hypothyroidism. Curr Opin Endocrinol Diabetes Obes. 2020;27(1):63\u20139.","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"4","key":"1061_CR8","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.nrl.2017.08.003","volume":"35","author":"L Garcia Morales","year":"2020","unstructured":"Garcia Morales L, Rodriguez Arnao MD, Rodriguez Sanchez A, Dulin Iniguez E, Alvarez Gonzalez MA. Sustained attention in school-age children with congenital hypothyroidism: influence of episodes of overtreatment in the first three years of life. Neurologia. 2020;35(4):226\u201332.","journal-title":"Neurologia"},{"issue":"3","key":"1061_CR9","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/S0022-3476(75)80963-2","volume":"86","author":"JL Penfold","year":"1975","unstructured":"Penfold JL, Simpson DA. Premature craniosynostosis-a complication of thyroid replacement therapy. J Pediatr. 1975;86(3):360\u20133.","journal-title":"J Pediatr"},{"issue":"11","key":"1061_CR10","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1097\/PEC.0000000000001141","volume":"35","author":"AB Ergul","year":"2019","unstructured":"Ergul AB, Altuner Torun Y, Serbetci MC, Ozcan A, Bas VN. Clinical toxicity of acute overdoses with L-thyroxin in children. Pediatr Emerg Care. 2019;35(11):787\u201390.","journal-title":"Pediatr Emerg Care"},{"issue":"3","key":"1061_CR11","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/S0022-3476(95)70452-3","volume":"126","author":"JF Rovet","year":"1995","unstructured":"Rovet JF, Ehrlich RM. Long-term effects of L-thyroxine therapy for congenital hypothyroidism. J Pediatr. 1995;126(3):380\u20136.","journal-title":"J Pediatr"},{"key":"1061_CR12","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.amsu.2020.09.045","volume":"59","author":"KC Kiran Kumar","year":"2020","unstructured":"Kiran Kumar KC, Ghimire N, Limbu T, Khapung R. Levothyroxine overdose in a hypothyroid patient with adjustment disorder: a case report. Ann Med Surg (Lond). 2020;59:234\u20136.","journal-title":"Ann Med Surg (Lond)"},{"issue":"4","key":"1061_CR13","doi-asserted-by":"publisher","first-page":"565","DOI":"10.4103\/2230-8210.98012","volume":"16","author":"AT Soliman","year":"2012","unstructured":"Soliman AT, Azzam S, Elawwa A, Saleem W, Sabt A. Linear growth and neurodevelopmental outcome of children with congenital hypothyroidism detected by neonatal screening: a controlled study. Indian J Endocrinol Metab. 2012;16(4):565\u20138.","journal-title":"Indian J Endocrinol Metab"},{"issue":"6","key":"1061_CR14","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1515\/jpem-2017-0513","volume":"31","author":"M Craven","year":"2018","unstructured":"Craven M, Frank GR. Does initial dosing of levothyroxine in infants with congenital hypothyroidism lead to frequent dose adjustments secondary to iatrogenic hyperthyroidism on follow-up? J Pediatr Endocrinol Metab. 2018;31(6):597\u2013600.","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"1","key":"1061_CR15","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1111\/j.1365-2265.2008.03172.x","volume":"69","author":"S Mathai","year":"2008","unstructured":"Mathai S, Cutfield WS, Gunn AJ, Webster D, Jefferies C, Robinson E, et al. A novel therapeutic paradigm to treat congenital hypothyroidism. Clin Endocrinol. 2008;69(1):142\u20137.","journal-title":"Clin Endocrinol"},{"issue":"4","key":"1061_CR16","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1046\/j.1365-2265.2002.01632.x","volume":"57","author":"B Bakker","year":"2002","unstructured":"Bakker B, Kempers MJ, De Vijlder JJ, Van Tijn DA, Wiedijk BM, Van Bruggen M, et al. Dynamics of the plasma concentrations of TSH, FT4, and T3 following thyroxine supplementation in congenital hypothyroidism. Clin Endocrinol. 2002;57(4):529\u201337.","journal-title":"Clin Endocrinol"},{"issue":"2","key":"1061_CR17","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1515\/jpem-2015-0047","volume":"29","author":"H Tuhan","year":"2016","unstructured":"Tuhan H, Abaci A, Cicek G, Anik A, Catli G, Demir K, et al. Levothyroxine replacement in primary congenital hypothyroidism: the higher the initial dose, the higher the rate of overtreatment. J Pediatr Endocrinol Metab. 2016;29(2):133\u20138.","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"3","key":"1061_CR18","first-page":"195","volume":"36","author":"A Cassio","year":"2013","unstructured":"Cassio A, Corbetta C, Antonozzi I, Calaciura F, Caruso U, Cesaretti G, et al. The Italian screening program for primary congenital hypothyroidism: actions to improve screening, diagnosis, follow-up, and surveillance. J Endocrinol Investig. 2013;36(3):195\u2013203.","journal-title":"J Endocrinol Investig"},{"issue":"6","key":"1061_CR19","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1111\/j.1651-2227.2003.tb00603.x","volume":"92","author":"M Adachi","year":"2003","unstructured":"Adachi M, Asakura Y, Tachibana K. Final height and pubertal growth in Japanese patients with congenital hypothyroidism detected by neonatal screening. Acta Paediatr. 2003;92(6):698\u2013703.","journal-title":"Acta Paediatr"},{"issue":"3","key":"1061_CR20","doi-asserted-by":"publisher","first-page":"R51","DOI":"10.1530\/JOE-15-0341","volume":"227","author":"N Schoenmakers","year":"2015","unstructured":"Schoenmakers N, Alatzoglou KS, Chatterjee VK, Dattani MT. Recent advances in central congenital hypothyroidism. J Endocrinol. 2015;227(3):R51\u201371.","journal-title":"J Endocrinol"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-022-01061-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12902-022-01061-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-022-01061-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T10:10:22Z","timestamp":1700647822000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcendocrdisord.biomedcentral.com\/articles\/10.1186\/s12902-022-01061-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,28]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1061"],"URL":"https:\/\/doi.org\/10.1186\/s12902-022-01061-z","relation":{},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,28]]},"assertion":[{"value":"23 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the research ethics committee of The First People\u2019s Hospital of Yunnan Province. (Approval number: 2013LW001). All legal guardians of patients had been informed and signed the informed consent form. We obey the principles of the 2004 Declaration of Helsinki. In other words, all methods adopted in this paper obey these principles.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"142"}}